ReviewWorld journal of pediatric surgery2026
Postoperative hyperinflammation and recovery challenges in necrotizingenterocolitis.
Review in World journal of pediatric surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing enterocolitis (NEC) remains one of the most devastating gastrointestinal emergencies in neonates, particularly affecting premature infants with immature intestinal, immune and microvascular systems. While surgical intervention is often lifesaving in severe NEC, the postoperative period introduces distinct challenges that critically influence survival and long-term outcomes. This review examines postoperative hyperinflammation as a central driver of morbidity following surgical NEC. Despite resection of necrotic bowel, many infants experience persistent systemic inflammation characterized by dysregulated innate immune activation, excessive cytokine release and sustained gut barrier dysfunction. Key mediators including tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, IL-1β and IL-8 contribute to endothelial injury, capillary leak, hemodynamic instability and multiorgan dysfunction. Ongoing intestinal permeability and microbial translocation perpetuate inflammatory signaling, delaying mucosal healing and predisposing infants to recurrent NEC, sepsis and short bowel syndrome. Clinically, postoperative hyperinflammation manifests as systemic inflammatory response syndrome, coagulopathy, feeding intolerance, impaired wound healing and neurodevelopmental injury. Recovery is frequently prolonged by nutritional compromise, dependence on parenteral nutrition and recurrent infections, which further amplify inflammatory stress. Current management remains largely supportive, focusing on optimization of nutrition, infection prevention and multidisciplinary care. Emerging immunomodulatory and microbiome-based therapies remain investigational. Postoperative hyperinflammation remains a difficult and complex sequelae of NEC and future investigation is needed to improve long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.